114 related articles for article (PubMed ID: 7784090)
1. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation.
Tsang NM; Nagasawa H; Li C; Little JB
Oncogene; 1995 Jun; 10(12):2403-8. PubMed ID: 7784090
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation.
Huang H; Li CY; Little JB
Int J Radiat Biol; 1996 Aug; 70(2):151-60. PubMed ID: 8794844
[TBL] [Abstract][Full Text] [Related]
3. Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene.
Demers GW; Halbert CL; Galloway DA
Virology; 1994 Jan; 198(1):169-74. PubMed ID: 8259651
[TBL] [Abstract][Full Text] [Related]
4. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
Fan S; Smith ML; Rivet DJ; Duba D; Zhan Q; Kohn KW; Fornace AJ; O'Connor PM
Cancer Res; 1995 Apr; 55(8):1649-54. PubMed ID: 7712469
[TBL] [Abstract][Full Text] [Related]
5. p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts.
Cistulli CA; Kaufmann WK
Cancer Res; 1998 May; 58(9):1993-2002. PubMed ID: 9581844
[TBL] [Abstract][Full Text] [Related]
6. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
Rampias T; Sasaki C; Weinberger P; Psyrri A
J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras.
Bristow RG; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
Oncogene; 1994 Jun; 9(6):1527-36. PubMed ID: 8183546
[TBL] [Abstract][Full Text] [Related]
8. Increased ultraviolet sensitivity and chromosomal instability related to P53 function in the xeroderma pigmentosum variant.
Cleaver JE; Afzal V; Feeney L; McDowell M; Sadinski W; Volpe JP; Busch DB; Coleman DM; Ziffer DW; Yu Y; Nagasawa H; Little JB
Cancer Res; 1999 Mar; 59(5):1102-8. PubMed ID: 10070969
[TBL] [Abstract][Full Text] [Related]
9. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of radiation-inducible telomerase upregulation in HPV16 E6 transfectants of human lymphoblasts.
Neuhof D; Auberger F; Ruess A; Wenz F; Weber KJ
Strahlenther Onkol; 2004 Jan; 180(1):52-6. PubMed ID: 14704845
[TBL] [Abstract][Full Text] [Related]
11. Down regulation of p53 with HPV E6 delays and modifies cell death in oxidant response of human diploid fibroblasts: an apoptosis-like cell death associated with mitosis.
Chen QM; Merrett JB; Dilley T; Purdom S
Oncogene; 2002 Aug; 21(34):5313-24. PubMed ID: 12149652
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.
Thomas M; Matlashewski G; Pim D; Banks L
Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365
[TBL] [Abstract][Full Text] [Related]
13. Alteration of cell-cycle regulatory proteins in human oral epithelial cells immortalized by HPV16 E6 and E7.
Sdek P; Zhang ZY; Cao J; Pan HY; Chen WT; Zheng JW
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):653-7. PubMed ID: 16513324
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
[TBL] [Abstract][Full Text] [Related]
15. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts.
Shay JW; Wright WE; Brasiskyte D; Van der Haegen BA
Oncogene; 1993 Jun; 8(6):1407-13. PubMed ID: 8389027
[TBL] [Abstract][Full Text] [Related]
16. Dispensability of p53 degradation for tumorigenicity and decreased serum requirement of human papillomavirus type 16 E6.
Inoue T; Oka K; Yong-Il H; Vousden KH; Kyo S; Jing P; Hakura A; Yutsudo M
Mol Carcinog; 1998 Mar; 21(3):215-22. PubMed ID: 9537653
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity.
McIlwrath AJ; Vasey PA; Ross GM; Brown R
Cancer Res; 1994 Jul; 54(14):3718-22. PubMed ID: 8033090
[TBL] [Abstract][Full Text] [Related]
18. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of p53-induced G1 arrest by the HPV 16 E7 protein does not inhibit p53-induced apoptosis.
Wang Y; Okan I; Pokrovskaja K; Wiman KG
Oncogene; 1996 Jun; 12(12):2731-5. PubMed ID: 8700534
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of p53 function by HPV16 E6 gene delays apoptosis and enhances mutagenesis but does not alter radiosensitivity in TK6 human lymphoblast cells.
Yu Y; Li CY; Little JB
Oncogene; 1997 Apr; 14(14):1661-7. PubMed ID: 9135067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
